DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sandborn WJ. et al.
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial.
Gut 2004; 53: 1485-1493
We do not assume any responsibility for the contents of the web pages of other providers.